NHWK News and Press, NightHawk Biosciences Inc. From 08/14/23

DURHAM, N.C., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) , a fully integrated biopharmaceutical company specializing in the end-to-end development, manufacturing, and commercialization of innovative medical countermeasures that combat unmet and emerg...

2023-06-14 09:04:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cineverse (NASDAQ: CNVS ) stock is falling on Wednesday after the company revealed the pricing of a public share offering. This stock offering has the global streaming techn...

2023-06-14 08:45:49 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Eastside Distilling (NASDAQ: EAST ) stock is taking a beating on Wednesday after the company revealed plans to trade debt for equity . The company says that it has signe...

2023-06-14 08:27:26 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Inventiva (NASDAQ: IVA ) stock is rising higher on Wednesday following the release of positive results from a Phase II clinical trial . This clinical trial has Inventiva...

2023-06-14 08:05:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips NightHawk Biosciences (NYSEMKT: NHWK ) stock is on the rise Wednesday despite a lack of news concerning the biopharmaceutical company. Investors will note that there have be...

2023-06-14 07:30:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the biggest pre-market stock movers as investors get ready to trade shares on Wednesday! Moving stocks this morning are clinical trial data, public sh...

2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...

2023-05-15 16:53:05 ET NightHawk Biosciences press release ( NYSE: NHWK ): Q1 GAAP EPS of -$0.49. As of March 31, 2023, the Company had approximately $28.6 million in cash, cash equivalents, and short-term investments. For further details see: NightHawk Bioscienc...

DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) , a fully integrated biopharmaceutical company specializing in the end-to-end development, manufacturing, and commercialization of innovative medical countermeasures that combat unmet and emergi...

2023-04-03 00:29:08 ET NightHawk Biosciences press release ( NYSE: NHWK ): FY GAAP EPS of -$1.70. Revenue of $6.4M (+204.8% Y/Y). As of December 31, 2022, the company had approximately $44.3M in cash, cash equivalents, and short-term investments. For further deta...